Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

About 30k shares in 15 minutes at 3.93-3.99 range

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Level2Me Member Profile
 
Followed By 38
Posts 4,510
Boards Moderated 0
Alias Born 10/21/14
160x600 placeholder
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insurance Provider GlobeNewswire Inc. - 1/25/2021 7:35:00 PM
Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascul... GlobeNewswire Inc. - 1/21/2021 4:30:00 PM
The FDA Calendar Review Dates Can Play a Big Role in Timing Your Trades, But Not the Way You May Think InvestorsHub NewsWire - 1/7/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2021 6:16:40 AM
Amarin Provides Preliminary 2020 Results and 2021 Outlook GlobeNewswire Inc. - 1/7/2021 6:05:00 AM
Amarin to Present at 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/4/2021 6:05:00 AM
Amarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (N... GlobeNewswire Inc. - 12/14/2020 5:00:00 AM
Amarin Reports Encouraging Efficacy and Safety Results from Pilot Study Treating COVID-19 Infected Outpatients with VASCEPA®... GlobeNewswire Inc. - 12/12/2020 9:30:00 PM
VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at National Lipid Association (NLA) Scientific Sessio... GlobeNewswire Inc. - 12/7/2020 7:00:00 AM
Amarin Files Patent Infringement Lawsuit Against Hikma GlobeNewswire Inc. - 11/30/2020 7:54:44 PM
Amarin to Present at Piper Sandler’s 32nd Annual Healthcare Conference (Virtual) GlobeNewswire Inc. - 11/24/2020 6:05:00 AM
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China GlobeNewswire Inc. - 11/19/2020 6:30:00 PM
Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association’s Virtual Scie... GlobeNewswire Inc. - 11/18/2020 7:00:00 AM
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Graft... GlobeNewswire Inc. - 11/13/2020 10:00:00 AM
Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences GlobeNewswire Inc. - 11/11/2020 4:30:00 PM
Epazz, Inc. (OTC Pink: EPAZ) and Zoom (NASDAQ: ZM) for a Covid-19 Surge InvestorsHub NewsWire - 11/9/2020 6:00:00 AM
Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire Inc. - 11/5/2020 6:00:00 AM
New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at American Heart Association’s Virtual Scienti... GlobeNewswire Inc. - 10/29/2020 7:00:10 AM
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Cardiovascular Events in Patients with Compromised Renal Function a... GlobeNewswire Inc. - 10/26/2020 7:00:10 AM
U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderat... GlobeNewswire Inc. - 10/23/2020 7:00:10 AM
Amarin to Report Third Quarter 2020 Results and Host Conference Call on November 5, 2020 GlobeNewswire Inc. - 10/19/2020 7:00:10 AM
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Interv... GlobeNewswire Inc. - 10/15/2020 4:30:10 PM
Latest Research Evaluating VASCEPA® (Icosapent Ethyl) Mechanisms of Action Presented at European Atherosclerosis Society (EA... GlobeNewswire Inc. - 10/5/2020 7:00:10 AM
Amarin to Present at the 2020 Cantor Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/9/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2020 4:21:33 PM
Level2Me   Tuesday, 09/22/20 08:26:48 PM
Re: None
Post # of 321618 
About 30k shares in 15 minutes at 3.93-3.99 range

“Know what you own, and know why you own it”
-P.L.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences